Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

BIO Issues Call for Papers for 2017 World Congress on Industrial Biotechnology in Montréal

Biotechnology Innovation Organization (BIO)
Posted on: 01 Nov 16

The Biotechnology Innovation Organization (BIO) today issued a call to leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors industries to submit panel session proposals for the 2017 World Congress on Industrial Biotechnology. The conference will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal, Canada.

“BIO is bringing the World Congress on Industrial Biotechnology back to Montréal because it is a strategic location for the formation of international partnerships to expand industrial biotechnology into new worldwide markets,” stated Brent Erickson, Executive Vice President, Industrial and Environmental at BIO. “BIO’s World Congress is inviting speakers to present the latest research and partnerships in renewable chemicals, advanced biofuels, global biobased markets, synthetic biology and much more.”

The 2016 World Congress on Industrial Biotechnology, held in San Diego, drew more than 900 industry leaders from 529 companies, 32 countries and 31 states, as well as the District of Columbia. The event hosted 1,961 partnering meetings, nearly a 40% increase from the 2015 BIO World Congress.

The call for sessions will open November 01, 2016 to invite submissions for breakout panels, posters, and Green Tech investor sessions. Leaders from the biotechnology industry, academia, and policy community are invited to offer an abstract or a panel proposal in any of the following program tracks:

  • Advanced Biofuels and Biorefinery Platforms
  • Renewable Chemicals and Biobased Materials
  • Agriculture Crop Technologies and Biomass Supply
  • Flavors, Fragrances and Food Ingredients
  • Synthetic Biology and Genomics Research
  • Research and Technical Presentations
  • Growing Global Biobased Markets

Proposed panels should address any in a range of topics, including renewable chemicals, algae for fuels and bioproducts, and chemicals, biobased products, biomass utilization, cellulosic biofuels, metabolic engineering, new chemical pathways, regional economic development, synthetic biology, regulatory issues, new feedstock crops and feedstock sustainability, aviation biofuels, genetically engineered crops, project finance, biopathways to bulk chemicals, enzyme development, green plastics, work force training and specialty chemicals.

For more information on the conference or to submit a proposal, please visit For assistance, please contact

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO Patient and Health Advocacy Summit
November 3-4, 2016
Washington, D.C.

BIO Europe
November 7-9, 2016
Cologne, Germany

BIO IP Councils Committee Conference
November 14-16, 2016
Savannah, GA

View source version on

Business Wire

Last updated on: 01/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.